Fournier, Elise <br/><br/>
Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in   [electronic resource] 

 -  Leukemia & lymphoma  07 2019 
 - 1827-1830 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Review 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2018.1562185  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antigens, CD19--immunology<br/>Female<br/>Gene Rearrangement<br/>Histone-Lysine N-Methyltransferase--genetics<br/>Humans<br/>Immunotherapy--adverse effects<br/>Leukemia, Myeloid, Acute--chemically induced<br/>Middle Aged<br/>Myeloid-Lymphoid Leukemia Protein--genetics<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prognosis